Shrinkhal*, Pragati Garg, Swarastra Prakash Singh and Ruchi Shukla
Department of Ophthalmology, All India Institute of Medical Sciences, Raebareli, Uttar Pradesh, India
*Corresponding Author: Shrinkhal, Department of Ophthalmology, All India Institute of Medical Sciences, Raebareli, Uttar Pradesh, India.
Received: March 16, 2023; Published: April 01, 2023
Giant cell arteritis (GCA) is a systemic disease, characterized by granulomatous inflammation of the large and medium sized arteries. It almost exclusively affects older than 50 years and is part of the spectrum including polymyalgia rheumatica. The incidence of GCA increases with the age. Women are affected more commonly than men. It can lead to profound permanent vision loss, if not detected early due to mainly arteritic anterior ischaemic optic neuropathy. The vision loss can occur within hours to days. If left untreated, around 50% of patients with GCA and vision loss in one eye will lose vision in the opposite eye within 7 days. Treatment is required even if the patient loses vision in the both the eyes, as GCA is a systemic disease.
Citation: Shrinkhal., et al. “Giant Cell Arteritis: A Clinical Challenge". Acta Scientific Neurology 6.5 (2023): 01-02.
Copyright: © 2023 Shrinkhal., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.